期刊文献+

肝动脉化疗栓塞联合射频消融技术治疗大肝癌的疗效分析 被引量:2

Effect Analysis of Hepatic Arterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Large Liver Cancer
暂未订购
导出
摘要 目的研究在大肝癌治疗中采用肝动脉化疗栓塞(transarterial chemoembolisation,TACE)联合射频消融技术(radiofrequency ablation,RFA)的疗效。方法选取2018年4月—2021年4月齐齐哈尔医学院附属第二医院介入科收治的40例大肝癌患者,按照奇数偶数分组法分为观察组与对照组,各20例。对照组采取TACE治疗,观察组采用TACE+RFA治疗。统计两组疾病缓解率,分析两组肝功能指标及随访1年后的生存率。结果观察组疾病缓解率为90.00%,高于对照组的60.00%,差异有统计学意义(χ2=4.800,P<0.05);治疗6个月后,两组的ALT、TBIL水平比较,差异无统计学意义(P>0.05),而观察组MTD、AFP水平低于对照组,差异有统计学意义(P<0.05);随访1年,观察组的生存率为95.00%高于对照组的70.00%,差异有统计学意义(P<0.05)。结论TACE联合RFA在治疗大肝癌中,疗效好,可改善肝功能指标。 Objective To investigate the efficacy of hepatic arterial chemoembolization(TACE)combined with radiofrequency ablation(RFA)in the treatment of large liver cancer.Methods Forty patients with large liver cancer admitted to the Department of Intervention of the Second Affiliated Hospital of Qiqihar Medical College from April 2018 to April 2021 were selected and divided into observation group and control group by odd-even grouping method,with 20 cases in each group.The control group received TACE treatment,and the observation group received TACE+RFA treatment.The remission rate,liver function index and survival rate of the two groups after 1 year follow-up were analyzed.Results The disease remission rate in the observation group was 90.00%higher than that in the control group(60.00%),and the difference was statistically significant(χ^(2)=4.800,P<0.05).After 6 months of treatment,there was no statistically significant difference in the levels of ALT and TBIL between the two groups(P>0.05),while the level of MTD and AFP in the observation group were lower than those in the control group,the difference was statistically significant(P<0.05).Following up for one year,the survival rate of the observation group was 95.00%higher than that of the control group,70.00%,the difference was statistically significant(P<0.05).Conclusion TACE combined with RFA is effective in the treatment of large liver cancer and can improve liver function indexes.
作者 杜友利 杨坡 马晓欧 王东旭 刘云龙 DU Youli;YANG Po;MA Xiao´ou;WANG Dongxu;LIU Yunlong(The Second Affiliated Hospital of Qiqihar Medical College,Qiqihar,Heilongjiang Province,161000 China;The Fourth Affiliated Hospital of Harbin Medical University,Qiqihar,Heilongjiang Province,150000 China)
出处 《世界复合医学》 2022年第12期70-73,共4页 World Journal of Complex Medicine
基金 2020年度齐齐哈尔医学科学院项目(QMSI2020M-10)。
关键词 肝动脉化疗栓塞 射频消融技术 大肝癌 疗效 Hepatic arterial chemoembolization Radiofrequency ablation technology Large liver cancer Curative effect
  • 相关文献

参考文献18

二级参考文献107

  • 1Shan Ke,Xue-Mei Ding,Xiao-Jun Qian,Yi-Ming Zhou,Bao-Xin Cao,Kun Gao,Wen-Bing Sun.Radiofrequency ablation of hepatocellular carcinoma sized> 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?[J].World Journal of Gastroenterology,2013,19(42):7389-7398. 被引量:24
  • 2王宁,杨海山.经动脉灌注化疗栓塞联合经皮瘤内乙醇注射治疗肝癌的进展[J].介入放射学杂志,2005,14(1):98-100. 被引量:11
  • 3Zhen-Wei Peng,Rong-Ping Guo,Yao-Jun Zhang.Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus. Cancer . 2012
  • 4Xu C, Lv PH, Huang XE, et al. Efficacy of transarterial chemo- embotization combined with radiofrequency ablation in treatment of hepatocellular carcinoma. Asian Pac J Cancer Prey, 2015, 16 (14) :6159-6162.
  • 5Peng ZW, Zhang YJ, Liang HH, et al. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoem bolization and RF ablation versus RF ablation alone: A prospec- tive randomized trial. Radiology, 2012,262(2):689-700.
  • 6N'Kontchou G, Mahamoudi A, Aout M, et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prog- nostic factors in 235 Western patients with cirrhosis. Hepatology, 2009,50(5) : 1475-1483.
  • 7Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: An institute's experience with 625 patients. J Am Coll Surg, 2007, 204(4) : 580-587.
  • 8Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hep- atocellular carcinoma as firswline treatment: Long-term results and prognostic factors in 162 patients with cirrhosis. Radiology, 2014,270(3) :900-909.
  • 9Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10 year outcome and prognostic fac- tors. Am J Gastroenterol, 2012,107(4) :569-577; quiz 578.
  • 10Roayaie S, Jibara G, Tabrizian P, et al. The role of hepatic re- section in the treatment of hepatocellular cancer. Hepatology, 2015,62(2) :440-451.

共引文献252

同被引文献25

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部